SCTaware: A Comprehensive Program to Increase Sickle Cell Trait Knowledge and Awareness Among Parents of Infants Identified by Newborn Screening
SCTaware:一项综合计划,旨在提高新生儿筛查发现的婴儿父母对镰状细胞性状的了解和认识
基本信息
- 批准号:9915969
- 负责人:
- 金额:$ 7.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-15 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAffectAfrican AmericanAgeAmericanAppointments and SchedulesAwarenessChildChronicClinicalConflict (Psychology)Decision MakingDevelopmentDiseaseEducationFaceFamilyFundingFutureGoalsHealthHealth educationHematological DiseaseHigh PrevalenceHome environmentIndividualInfantInterventionKnowledgeLeadLearningMeasuresNational Heart, Lung, and Blood InstituteNeedlesNeonatal ScreeningOhioOutcomePainParentsPatient Self-ReportPersonsPhobiasPreventionPublic HealthReportingResearchResearch PersonnelResourcesRiskSickle Cell AnemiaSickle Cell TraitSiteStrokeTestingTimeTrainingUncertaintyUnited Statesbaseblood treatmentcareercareer developmentchild bearingcosteffective therapyexperiencehealth literacyhydroxyureaimproved outcomeinnovationmortalitypreventprogramsrecruitreproductivesuccesstool
项目摘要
PROJECT SUMMARY/ABSTRACT
Nearly 3 million African Americans have sickle cell trait (SCT) and are at risk of having a child with sickle cell
disease (SCD), a severe and chronic blood disorder. More than 80% of these individuals do not know or
understand their SCT status, despite the significant implications that SCT status can have on future
reproductive decisions. Effectively educating parents of infants with SCT identified by newborn screening is
critical. These parents are key to passing on knowledge about SCT and SCD to their children with SCT as they
mature, and many of the parents can use this knowledge to inform their own future reproductive decisions,
since these parents are also presumed to have a high prevalence of SCT. However, preliminary studies
suggest that parents of infants with SCT frequently have low health literacy and baseline low SCT knowledge
that may limit their capacity to achieve high and sustained knowledge with the education that is currently
provided. The objectives of this proposal are to develop an engaging and effective health literacy-based
program (SCTaware) that makes on-site SCT testing available for parents and to identify barriers that may
prevent parents from knowing their own SCT status or from obtaining SCT testing. The central hypothesis is
that SCTaware education will be feasible to implement and will result in high and sustained parental knowledge
about SCT and SCD. With the successful completion of these objectives, SCTaware could be extended to
parents of children with SCD, who also have low knowledge and health literacy, to enable them to make
informed health decisions for their children and to increase utilization of and adherence to effective SCD
therapies (e.g., hydroxyurea). This application is directly responsive to the NHLBI Limited Competition R03
program for career development awardees (RFA-HL-18-025). Thus, completion of the proposed research is
expected to facilitate the development of a unique and needed resource (an effective SCD education program)
that will accelerate the career progression of a successful K23 awardee toward independence as a clinical
researcher. The PI will leverage this resource to successfully compete for R01 funding to determine the impact
that an effective SCD education program and an innovative hydroxyurea adherence intervention have on the
outcomes of children with SCD.
项目概要/摘要
近 300 万非裔美国人患有镰状细胞特征 (SCT),并且有生下患有镰状细胞的孩子的风险
疾病(SCD),一种严重的慢性血液疾病。其中超过 80% 的人不知道或
了解他们的 SCT 状态,尽管 SCT 状态可能对未来产生重大影响
生殖决定。对新生儿筛查发现的 SCT 婴儿父母进行有效教育是
批判的。这些父母是将 SCT 和 SCD 知识传授给患有 SCT 的孩子的关键,因为他们
成熟,许多父母可以利用这些知识来指导自己未来的生育决定,
因为这些父母也被认为有很高的 SCT 患病率。然而,初步研究
表明接受 SCT 的婴儿的父母通常健康素养较低且基线 SCT 知识较低
这可能会限制他们通过目前的教育获得高水平和持续知识的能力
假如。该提案的目标是开发一种有吸引力且有效的基于健康素养的方法
计划 (SCTaware),为家长提供现场 SCT 测试,并识别可能存在的障碍
阻止父母了解自己的 SCT 状态或获得 SCT 检测。中心假设是
SCTaware 教育将是可行的,并将带来高水平和持续的家长知识
关于 SCT 和 SCD。随着这些目标的成功完成,SCTaware 可以扩展到
患有SCD的儿童的家长,他们的知识和健康素养也较低,使他们能够
为孩子做出明智的健康决策,并提高对有效 SCD 的利用和坚持
疗法(例如羟基脲)。此应用程序直接响应 NHLBI 有限竞赛 R03
职业发展获奖者计划 (RFA-HL-18-025)。因此,完成拟议的研究是
预计将促进独特且所需资源的开发(有效的 SCD 教育计划)
这将加速成功的 K23 获奖者的职业发展,使其成为独立的临床医生
研究员。 PI 将利用此资源成功竞争 R01 资金以确定影响
有效的 SCD 教育计划和创新的羟基脲依从性干预措施对
SCD 儿童的结局。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Closing knowledge gaps among parents of children with sickle cell trait.
缩小镰状细胞性状儿童父母之间的知识差距。
- DOI:
- 发表时间:2023-07
- 期刊:
- 影响因子:3.2
- 作者:Beeman, Chase M;Abrams, Mary Ann;Zajo, Kristin;Stanek, Joseph;Martinez;Creary, Susan E
- 通讯作者:Creary, Susan E
A Health Literate Approach to Address Health Disparities: a Virtual Program for Parents of Children with Sickle Cell Trait.
解决健康差异的健康素养方法:针对镰状细胞性状儿童家长的虚拟计划。
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Abrams, Mary Ann;Zajo, Kristin N.;Beeman, Chase M.;O'Brien, Sarah H.;Chan, Peter K.;Shen, Yvette;McCorkle, Ben;Johnson, Latrice;Chisolm, Deena;Barnard-Kirk, Toyetta;Mahan, John D.;Christian-Rancy, Myra;Creary, Susan E.
- 通讯作者:Creary, Susan E.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Creary其他文献
Susan Creary的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan Creary', 18)}}的其他基金
ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)
ADHERE(对 HydroxyurEa 应用直接观察疗法以实现有效性)
- 批准号:
10698769 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
SMILE: Sickle Cell Disease Microbiologic and Immunologic Links to Health Equity
SMILE:镰状细胞病微生物学和免疫学与健康公平的联系
- 批准号:
10574746 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)
ADHERE(对 HydroxyurEa 应用直接观察疗法以实现有效性)
- 批准号:
10698769 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
A multidimensional strategy to improve hydroxyurea adherence in children with sickle cell
提高镰状细胞病儿童羟基脲依从性的多维策略
- 批准号:
8869788 - 财政年份:2015
- 资助金额:
$ 7.6万 - 项目类别:
相似国自然基金
社会网络关系对公司现金持有决策影响——基于共御风险的作用机制研究
- 批准号:72302067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高尿酸调控TXNIP驱动糖代谢重编程影响巨噬细胞功能
- 批准号:82370895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
倒装芯片超声键合微界面结构演变机理与影响规律
- 批准号:52305599
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
寒地城市学区建成环境对学龄儿童心理健康的影响机制与规划干预路径研究
- 批准号:52378051
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
原位研究聚变燃料纯化用Pd-Ag合金中Ag对辐照缺陷演化行为的影响及其相互作用机制
- 批准号:12305308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Proteomic and epigenetic alterations associated with plant-based diets and CVD
与植物性饮食和心血管疾病相关的蛋白质组学和表观遗传改变
- 批准号:
10643149 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)
芝加哥不同高危女性人群乳腺癌替代预防研究 (CAPSBRACA)
- 批准号:
10737279 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
种族和民族对接受 CDK4/6 抑制剂治疗的激素受体阳性乳腺癌患者预后的影响
- 批准号:
10762267 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
Exercise adherence and cognitive decline: Engaging with the Black community to develop and test a goal-setting and exercise intensity intervention
运动坚持和认知能力下降:与黑人社区合作制定和测试目标设定和运动强度干预措施
- 批准号:
10767102 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
帕比司他治疗成人镰状细胞病的 I 期研究:招募和保留的新方法
- 批准号:
10420453 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别: